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THE MICHIGAN MEDICAL MARIJUANA ACT: 
FIRST STEPS TOWARDS EFFECTIVE POLICY AND RESPONSIBLE PRACTICE  
 
 
AMY JACKSON 
Grand Valley State University 
 
Abstract 
 
Medical marijuana is becoming a socially acceptable means of medicating patients who 
receive palliative relief for their symptoms from its use.  This paper will examine the short 
history of the Michigan Medical Marijuana Act.  Has the state of Michigan crafted an effective 
medical marijuana policy?  Is this act effective for legislatures to implement and uphold?  Is it 
effective for patients using marijuana for its medicinal purposes?  Is it effective for providers 
trying to earn a living?  The research presented in this article shows that there are many 
undefined aspects of the law that create problems and opportunities for improvement.  Changes 
need to come from all parties involved.  Patients and caregivers need to work with legislators to 
ensure that the law is fair and effective.   
 
INTRODUCTION 
      
     On November 4, 2008, 68% of the voters in Michigan approved the Michigan Medical 
Marijuana Act.  This law allows citizens with a valid prescription to purchase and/or cultivate 
marijuana for medical use. Challenges have been brought against the legality of the law and 
different interpretations of how to enforce and uphold it.  Many patients have found relief from 
their symptoms and the law has allowed them to do this without fear of prosecution.  Some 
aspects of the law are not clearly defined, which has made both enforcing and following it a 
difficult path.   
 
LITERATURE REVIEW: MARIJUANA, MEDICINE, AND THE LAW 
 
History 
 
     Before 1937, well-known pharmaceutical companies such as Bristol Myers Squibb and Eli 
Lilly created at least 27 legal medications that contained marijuana.  In 1937 the Marijuana Tax 
Act was enacted, federally prohibiting the use of marijuana.  Dr. William C. Woodward of the 
American Medical Association opposed the Act, testifying that “prohibition would ultimately 
prevent the medical use of marijuana.”  The Controlled Substances Act of 1970 placed all illicit 
and prescription drugs into five ‘schedules’ (categories).  Marijuana was placed in schedule 1, 
defining it as having a high potential for abuse, no currently accepted safety for use in treatment 
in the United States, and a lack of accepted safety for use under medical supervision. Of course, 
at the time of the Controlled Substances Act, marijuana had been prohibited for more than three 
decades.  Its medicinal uses forgotten, marijuana was considered a dangerous and addictive 
narcotic (“Medicinal Benefits of Marijuana,” 2003).  Marijuana has a Schedule 1 classification 
and, like heroin, it is illegal for scientists to test its medical benefits on human subjects in the 
United States.   
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     It can be difficult for scientists and clinicians to perform research on a substance that has had 
a negative reputation for most of its existence and is currently classified as a Schedule 1 drug.  In 
order for one to perform research on a drug, in this case, an illicit drug, the clinician must get 
governmental permission and a supply from the National Institute on Drug Abuse.  Unless states 
decriminalize medical marijuana, obtaining it can be a questionable and illegal process.  
Noteworthy medical marijuana research has concluded that the use of marijuana was not fatal 
and did help those with chronic illnesses maintain their quality of life with minimal side effects. 
Furthermore, short term research suggests that cannabis, in its natural form, is an extremely safe 
and therapeutic substance when utilized in a supervised setting. Keeping marijuana in its natural 
form is what worries physicians who are actually allowed to prescribe the medication.  Even 
when a person has been cleared to qualify for the use of medical marijuana, it still brings up the 
question as to where they may obtain this medicine, especially within the United States.  Patients 
must obtain this on their own without help from their doctors or are allowed to grow their own 
within their home, as long as it does not exceed a certain amount or weight, which differs from 
state-to-state.  
     The Food and Drug Administration (FDA) is “the sole Federal agency that approves drug 
products as safe and effective for intended indications” (FDA, 2009).  If a drug does not receive 
the FDA’s stamp of approval, it is deemed unsafe and, in the case of marijuana, is classified as 
an illegal substance.  Although cannabis has been classified as an illegal substance, eighteen 
states have voted for its medical use.  California alone has over 100,000 medical marijuana users 
(Jacobs, 2005).   
 
Medicinal Uses of Marijuana 
 
     The use of marijuana is said to impair judgment and short term memory, increase infection 
within the upper respiratory system, cause hallucinations, increase one’s heart rate, and decrease 
coordination and psychomotor skills.  So why would anyone choose to utilize such a drug for 
medicinal purposes? There are many positive medicinal qualities to marijuana that aid those with 
chronic illnesses.  Some of these chronic illnesses where benefits are seen include AIDS, cancer, 
chronic pain, glaucoma, multiple sclerosis, and anxiety.  Most of these illnesses force the patient 
to undergo extensive treatment in order to fight against their disease. 
     The Institute of Medicine has concluded that, “For patients such as those with AIDS or who 
are undergoing chemotherapy and who suffer simultaneously from severe pain, nausea, and 
appetite loss, cannabinoid drugs might offer broad spectrum relief not found in any other single 
medication (“Medicinal Benefits of Marijuana,” 2003).  This is especially important for patients 
with diseases like AIDS because they suffer from multiple symptoms and are prescribed multiple 
drugs to treat their symptoms.  Medical marijuana, however, can reduce and alleviate many of 
the aforementioned symptoms as well as eliminate the prescribed drugs side effects.  Conversely, 
those with or who have had a previous history of immune system deficits are not encouraged to 
utilize such a drug because of a weakened immune system.  Smoke tends to damage the cells in 
the lining of the bronchial passageway.  These cells are what protect the body from outside 
microorganisms that can potentially increase the rate of bacteria and infection within this lining.  
Thus, those with HIV or AIDS may be more prone to pneumonia that may only advance the 
current stage of their disease.  Harvard researchers reported in the journal Cancer Research in 
2007 that “the active ingredient in marijuana can increase the risk for Kaposi’s sarcoma, a 
common cancer in HIV/AIDS patients” (Foreman, 2009). 
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     Medical marijuana is used to treat glaucoma, the leading cause of blindness in the United 
States.  Over time, one’s vision is damaged by increased intraocular pressure on the eye.  This 
pressure can be reduced by smoking marijuana.  Reducing this pressure also helps with the pain 
associated with the disease.  In some cases it has even been shown to slow the progression of 
glaucoma.  There are negative responses as well.  “Some potentially serious side effects were 
noted, including  an increased heart rate and a decrease in blood pressure in studies using 
smoked marijuana  The identification of side effects of smoked marijuana, coupled with the 
emergence of highly effective FDA-approved medications for glaucoma treatment, may have led 
to diminished research in this area” (Glaucoma and Marijuana Use, 2009).     
     Marijuana has also been found to be effective in the treatment of cancer and its side effects. 
When one determines that he or she has cancer, an option is to undergo chemotherapy to attack 
the cancer tumor.  Like any drug or treatment protocol, side effects can be extremely hard on the 
body, making it difficult to live and carry out normal activities of daily living.  A 2003 study 
found “Cannabinoids – the active components of Cannabis sativa and their derivatives – exert 
palliative effects in cancer patients by preventing nausea, vomiting and pain and by stimulating 
appetite.  In addition, these compounds have been shown to inhibit the growth of tumor cells in 
culture and animal models by modulating key cell-signaling pathways.  Cannabinoids are usually 
well tolerated, and do not produce the generalized toxic effects of conventional chemotherapies” 
(Medicinal Benefits of Marijuana, 2003).   If indeed marijuana can inhibit the growth of cancer, 
the medical benefits would be significant in the oncology field.  If more research can be 
performed on humans, now knowing that the use of cannabis is not fatal, however highly 
addictive, could marijuana be a potential outlet for those with cancer?  In 1995, it was concluded, 
“based on thirty years of scientific research that the smoking of cannabis, even long term, is not 
harmful to health." (British Medical Journal, 1995) 
     “An estimated 350,000 people in the United States are living with multiple sclerosis, a 
debilitating and sometime fatal disorder of the central nervous system.  Symptoms vary 
considerably from person to person; however, one frequently noted concomitant is spasticity, 
which causes pain, spasms, loss of function and difficulties in nursing care” (“Medicinal Benefits 
of Marijuana,” 2003).  Marijuana has been shown to relieve some of the symptoms of spasticity.  
When tested on animals, it was also shown to slow the progression on MS.  “A 2003 study that 
the American MS Society calls ‘interesting and potentially exciting’ demonstrated that 
cannabinoids were able to slow the disease process in mice by offering neuroprotection against 
experimental allergic encephalomyelitis (“Medicinal Benefits of Marijuana,” 2003).     Marijuana 
has been shown to be very effective in the treatment of chronic pain.  Chronic pain is ongoing 
and affects an individual’s ability to function normally in their day to day life.  The medicine 
given to alleviate the pain can cause nausea.  “Marijuana can provide relief from the pain itself 
(either alone or in combination with other analgesics), and it can control the nausea associated 
with taking opioid drugs, as well as the nausea, vomiting and dizziness that often accompany 
severe prolonged pain (“Medicinal Benefits of Marijuana,” 2003).  Because of its effectiveness 
with chronic pain, many unlikely advocates are coming forward.  One of these advocates is Mary 
Duda, a former home health aide with four children and two granddaughters.  “Marijuana,” says 
the 48-year-old Ware, Mass., resident, “is the only thing that even begins to control the migraine 
headaches that plagued me nine days a month.”  She always had these painful headaches but they 
got much worse 10 years after two operations to remove life threatening aneurysms, weak areas 
in the blood vessels in her brain.  None of the standard drugs her doctors prescribe help much 
with her post-surgical symptoms, which include nausea, vomiting, loss of appetite and pain on 
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her left side “as if my body were cut in half.”  “With marijuana, however, I can leave the dark 
room,” she says, “and it makes me eat a lot of food (Foreman, 2009).”      
 
Delivery Methods 
 
     “The federal government’s National Institute on Drug Abuse says that it has ‘not yet 
determined’ whether marijuana increases the risk for lung and other cancers (Foreman, 2009).”  
Many marijuana users also use other harmful products, such as tobacco, so this makes it difficult 
to pinpoint the exact causes of the cancer.  “3-4 cannabis cigarettes a day are associated with the 
same evidence of acute and chronic bronchitis and the same degree of damage to the bronchial 
mucosa as 20 or more tobacco cigarettes a day” (British Lung Foundation, 2002).  There was a 
study performed at the Medical Research Institute of New Zealand that “does acknowledge the 
difficulty of studying links between marijuana use and cancer, noting that the illegality of the 
drug, in addition to the tendency for its use to be combined with the use of other substances, can 
have an impact on the accuracy of the results.  The study does find a clear link, however, 
between the regular use of cannabis and increased risk for lung cancer.  From a common sense 
point of view, filling your lungs regularly with any type of smoke probably isn’t going to be 
good for your health” (Does Smoking Marijuana Give you Cancer, 2008).   
     There are some other options that could be utilized instead of inhaling smoke in to the lungs.  
“The goal of clinical trials of smoked marijuana would not be to develop marijuana as a licensed 
drug, but rather as a first step towards the possible development of nonsmoked, rapid-onset 
cannabinoid delivery systems” (Marijuana and Medicine – Assessing the Science Base, 1999).  
Inhalers could play an important role in this process.  Other options, such as ingesting the 
marijuana or using a vaporizer, eliminate the smoke inhalation.  It can be incorporated in to food 
products and eaten that way.  The issue with putting it in food products is that it is difficult to 
control the THC level and produce a consistent product.  “Vaporizing is a safe and effective way 
of getting THC, the active ingredient, into the bloodstream and does not result in the in 
inhalation of toxic carbon monoxide, as smoking does,” according to a study by Abrams 
published in 2007 in Clinical Pharmacology and Therapeutics (Foreman, 2009).  A new trend 
emerging that is very effective is making a cannabis tincture.  In this process, marijuana is 
combined with a high proof alcohol and administered from a dropper sublingually.  This allows 
the patient to control the dose and is easily administered in public if necessary.  Tincture was the 
common delivery method prior to the 1937 Marijuana Tax Act.  
     In 1985, the FDA approved a synthetic pill form of medical marijuana called Marinol.   This 
reduces the potential damage from smoking the plant.  It does not seem to have the same impact 
that actual marijuana has on the various ailments and symptoms it is meant to alleviate.  In many 
instances, marijuana is used to combat nausea.  When you are smoking, you feel the effects 
immediately.  With Marinol, it can take up to an hour and a half to feel its effects.    It can also 
be hard to keep pills down when you are feeling nauseous.  “Marinol is not the same thing as 
traditional smokable marijuana.  It is a less complex substance lacking both some of the good 
components found in traditional marijuana (such as cannabidiol, which has been found to have 
anti-seizure effects) and the bad or not-yet-fully understood components (among them the 
potential carcinogens) that can also come with the drug” (Montoli, 2009).  Because medical 
testing is not done on human subjects for the benefits of marijuana, it is difficult to know if there 
are medicinal affects received from the plant that are not able to be reproduced in Marinol.  Dr. 
Herbert Kleber, a professor of Psychiatry at Columbia University and the former deputy drug 
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czar under President H.W. Bush asks “Are there actions in the plant that you don’t get from just 
the Marinol?  I would be surprised if there wasn’t.  The problem is that most of the data about 
the potential medical actions of the smoked form are anecdotal” (Montoli, 2009). 
     An interesting drug developed by GW Pharmaceuticals in the United Kingdom is very similar 
to the cannabis plant but has been modified into a pill form called Sativex.  Sativex contains a 
cannabis extract containing THC that does not allow the patient to become intoxicated.  “This 
drug is a sublingual spray that has been approved for clinical use in Canada on July 16, 2009 for 
those suffering from multiple sclerosis and neuropathic pain.  This drug has been approved by 
the FDA in the United States for a Phase II clinical study” (GW Pharmaceuticals, 2010).  The 
company is hopeful that they will have FDA approval by the end of 2013.  Many other countries, 
including the United States, are beginning to jump on board with further research. Dr. Stephen 
Wright, GW’s R&D Director, said, “We are very pleased to have successfully completed two 
Phase II studies showing positive data supporting the efficacy of Sativex in cancer pain. We are 
now working closely with Otsuka in preparing for Phase III development of Sativex in the 
United States market” (GW Pharmaceuticals, 2010). 
 
State vs. Federal Law 
 
     Since medical marijuana is one of the most widely supported issues in drug policy reform, it 
is important to discuss both federal and state stances on the issue.  As many places started to 
legalize medical marijuana following the passage of California’s Compassionate Use Act, 
conflict between state and federal jurisdiction over the drug began to arise. The federal 
government does not permit cannabis to be used medicinally and has traditionally taken an active 
stance on enforcing this by various DEA drug raids into medical marijuana co-ops and 
dispensaries.  Many times these raids result in the inability for a clinic to re-open and therefore 
many patients must seek medicine elsewhere.  An employee of the Beach center Collective in 
Playa Del Ray said of the recent raid on their collective everything was taken.   “You name it; 
they took it -- right down to the television. The computer, patient files, medicine, cash in the 
register -- that’s it, we’re done. It’s just too bad. [Our patients] have epilepsy, cancer, MS, 
diabetes -- two of our patients have one leg. They’re gonna have to travel a lot farther and go to 
places that aren’t as safe for them (Knoll, 2009).”   
     Despite the DEA’s strong stance on upholding the Controlled Substances Act through raids 
and arrests, President Obama’s Administration is loosening up on the medical marijuana 
industry. In October of 2009, Attorney General Eric Holder announced that the administration 
will encourage federal prosecutors to stop pursuing cases against medical marijuana patients that 
are in compliance with state law. Instead Holder suggests the DEA focus on cases involving 
higher level drug traffickers, money launderers or people who use the state laws as a cover. This 
change represents a huge shift in previously enforced federal control over states that permit the 
use of medicinal marijuana. Many people feel this is the first big step towards putting jurisdiction 
into the hands of the states and thus, has encouraged support from both patients and advocacy 
groups. Other people were not so happy, such as Republican Lamar Smith of Texas; also the top 
Republican on the House Judiciary Committee.  "We cannot hope to eradicate the drug trade if 
we do not first address the cash cow for most drug-trafficking organizations -- marijuana 
(Johnson, 2009).” Currently the states that have enacted some version of legal medicinal 
marijuana into state law are, Alaska, Arizona, California, Colorado, Connecticut, Delaware, 
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Hawaii, Maine, Massachusetts, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, 
Rhode Island, Vermont, Washington, and the District of Columbia.   
     Now the question arises, “What are the roles of both patients and caregivers in this new law?” 
Each participating medicinal marijuana state differs in the amount of marijuana allowed to be 
possessed and number of plants a patient or caregiver may grow.  Michigan’s law states that the 
patients must begin the application process for a medical marijuana license through the Michigan 
Department of Community Health and must have a valid statement of need from a qualifying 
Michigan M.D or D.O. The qualifying physician does not actually write a prescription for 
marijuana as it is illegal to do so because of marijuana’s federal classification as a Schedule I 
drug.  Instead, the physician provides a written certification that states the applicant is a 
qualifying patient indicating his or her medical condition. The patient must also submit a $100 
new or renewal fee with their application, unless they are covered under a state health insurance 
plan in which they will pay $25.00.  Currently, Michigan has over 200,000 registered patients.  
Once an individual is registered, a card is received that can be shown as proof of registration.  
The patient is allowed to designate one caregiver 21 years of age or older who is responsible to 
obtain and grow marijuana for them if they are too sick or unable to grow the plant themselves. 
The caregiver or patient can acquire 2.5 ounces of usable marijuana and grow up to 12 marijuana 
plants for each qualifying patient.  The caregiver may assist up to 5 patients. The caregiver must 
sign a statement agreeing to provide marijuana only to the qualifying patients who have named 
the individual as their caregiver. The state does not provide information on where to obtain seeds 
or how to start the growing process; this is up to the patients and/or their caregivers (Department 
of Licensing and Regulatory Affairs). 
     Continuing to investigate the policy and regulations of Michigan’s Medical Marihuana Act 
(enacted November 4, 2008), there are rules associated with where you can smoke and grow 
your marijuana, employment related questions, and information regarding drug paraphernalia. 
Michigan law does not permit any person to do any of the following: 
 
 (1) Undertake any task under the influence of marijuana, when doing so would constitute    
negligence or professional malpractice. 
 (2) Possess marijuana, or otherwise engage in the medical use of marijuana: 
   (a) in a school bus; 
 (b) on the grounds of any preschool or primary or secondary school; or 
  (c) in any correctional facility. 
(3) Smoke marijuana: 
(a) on any form of public transportation;   or 
(b) in any public place. 
 (4) Operate, navigate, or be in actual physical control of any motor vehicle, aircraft, or 
motorboat while under the influence of marijuana (MDCH). 
 
     Furthermore, the law leaves the right of a patient to smoke marijuana up to his/her employer 
to decide if it is permissible or not, as the Michigan Medical Marihuana Act (MMMA) states that 
employers are not required to accommodate employees who use medical marijuana. Another 
provision under the law is that no patient can be prosecuted for using paraphernalia relating to 
the consumption of marijuana (Department of Licensing and Regulatory Affairs). 
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Dispensaries 
 
     When the Michigan Medical Marihuana Act (MMMA) was enacted in 2008, legislatures, 
patients, and caregivers agreed that the law is ambiguous.  A prime example of this is the 
ongoing debate of the legality of dispensaries.  A medical marijuana dispensary is a business that 
a patient with a medical marijuana card can go to and purchase medicine.  How does a 
dispensary work?  Patients or caregivers bring in their excess medicine.  Each caregiver can 
grow 12 plants per patient and can care for up to 5 patients.  Including growing for personal 
consumption, a caregiver can poses a total of 60 plants.  A total of 15 ounces of useable medicine 
can be possessed.  That is 2.5 ounces per patient, plus what is allowed for the caregiver.  15 
ounces is now called a Michigan Pound. In this scenario, a patient or caregiver may have extra 
medicine that they cannot legally have.  Because the law states that patients can transfer 
medicine to another patient, they transfer their excess medicine to the dispensary.  When the law 
originally passed, numerous dispensaries opened throughout the state and were thriving.  This 
helped alleviate the complication of patients who are prescribed the medicine, but do not know 
anyone who could be their caregiver.  Many of these patients are too sick to grow marijuana for 
their own use.  On August 24, 2011, the Michigan Court of Appeals ruled the commercial sale of 
medical marijuana, patient to patient, illegal.  This put dispensaries in violation of the law and in 
jeopardy of prosecution.  Under Michigan’s Public Nuisance law, these businesses can be forced 
to close.  Lansing is a great example of this boom and its subsequent demise (Kullgren, 2011).   
     Capital City Caregivers was owned by Michael and Anne Doyle and opened in May of 2010.  
Much time was spent working with local legislatures to ensure that the business was within the 
guidelines of the law.  The dispensary was modeled after California and Colorado and opened as 
a non-profit organization.  Donations of medicine were accepted and all profits were reinvested 
back to the company and community.  They rented a building on Michigan Avenue.  This area of 
Lansing is economically depressed and local business is imperative to its revitalization.  The 
Doyles spent their time and resources renovating the space and rented out two other suites, one 
to a massage therapist, the other to a shop that supplied growing supplies to budding 
horticulturalists.   
     Lansing had lengthy council meetings to create and license dispensaries within its borders.  
Ann Arbor had already created licensing regulations and Lansing modeled theirs after Ann 
Arbor.  One month after Lansing began accepting applications and licensing fees, Isabella 
County’s appellate court ruled that dispensaries were illegal according to the MMMA.  The court 
ruled that patients were not able to transfer excess medicine to another patient.  This was the 
premise that Capital City Caregivers operated under; that patient to patient transfer was legal.  
This appellate ruling shook things up in not only Lansing, but the entire state of Michigan. The 
city attorney, Brig Smith, sent letters advising all dispensaries to "cease and desist,” shut their 
doors, or face possible prosecution.  In August 2011, Capital City Caregivers complied, under 
advice of their lawyer.  The Doyle family had put all of their resources and efforts into this small 
business only to have to close their doors or risk having their family torn apart.  On October 11, 
2012, the Michigan Supreme Court heard arguments regarding the legality of dispensaries and is 
expected to rule sometime in early 2013.    
     Not allowing dispensaries creates problems for patients that are genuinely helped by this 
medicine.  A patient of Capital City Caregivers was a 62 year old woman.  She had cancer that 
had metastasized through her body.  It was very painful and difficult for her to get around.  She 
used marijuana in tincture form.  In the past, when she had been out running errands, the pain 
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would become so unbearable that she would have to go home.  With the tincture, when the pain 
would become unbearable, she would put a couple drops under her tongue and was able to 
continue on with her activities of daily living.  When the dispensary closed, she was not 
comfortable going to a caregiver and unable to grow it for herself.  She also preferred the tincture 
to inhaling smoke.  Tincture is more discreet and did not have adverse effects on her lungs.  She 
is a patient that was being helped but is now left behind.   
 
Trust 
 
     Trust plays an important role in governance, especially if there are competing values.  In the 
case of medical marijuana, there are two camps, one that thinks it should be legal, and the other 
that does not.  There is no trust in the other side.  Because of this, there is no transparency.  Both 
sides display opportunistic behavior.  Many medical marijuana patients are not in need of the 
drug to improve their health status.  An example of this is a patient I spoke with.  He was a large 
man, about 6’2” and 275 pounds, and 35 years old.  He was prescribed marijuana because he has 
chronic pain in his knee.  Though marijuana helps alleviate chronic pain, sitting all day and 
“getting high” does not facilitate rehabilitation for the underlying issue.  Physical rehab and 
exercise, as well as losing weight could, and most likely would, get rid of the pain all together.  
An attempt should be made to alleviate this issue before a lifetime of misuse results in surgery.  
A common complaint of the opposition is that the state has been too lax in handing out medical 
marijuana cards to patients.  Caregivers may not have any experience in growing marijuana or 
assisting patients, but they see an opportunity to make money.  They are not taking into account 
that there are patients whose lives are improved by medicine and want the highest quality 
product.  The legislature has no trust in patients or caregivers, and many see this as a slippery 
slope toward the legalization of marijuana.  An example of this mistrust happened in Lansing.  A 
Lansing citizen was a financial partner in Capital City Caregivers.  He had been an outspoken 
advocate of medical marijuana.  When the business was forced to close and he lost his 
investment, he became a caregiver and started growing a legal amount of marijuana in a 
warehouse with another caregiver.  That warehouse was raided by federal agents and everything 
was confiscated, down to the mini-refrigerator with his lunch in it.  He was arrested.  When he 
was questioned about his business, he was told by the federal agents that he needed to remove 
himself from the spotlight.  All of the serious drug charges were dropped and he was allowed to 
leave police custody, but, as of today, has not been returned any of his belongings.  If the two 
sides could learn to trust each other, which will take time, there is a chance for learning, stability, 
and growth. 
 
Economic Benefits 
 
     Can the legalization of medical marijuana play a role in reducing costs in our health care 
system?  Medical marijuana, as a prescribed medication, is inexpensive to produce.  
Furthermore, it can be prescribed medication that virtually anyone can procure (with active 
dispensaries).  Many pharmaceutical companies greatly oppose the legalization of medical 
marijuana and its coverage under health insurance; legalized medical marijuana takes money out 
of the pharmaceutical coffers.  Health care costs for prescription drug coverage could be 
dramatically reduced if a cheaper alternative is introduced to the consumer market.  
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Pharmaceutical companies would have to compete and we could see many of the high priced 
pharmaceuticals drop in price. 
     For this reduction in cost, not only the patients, but the employers responsible for paying for 
these insurance packages need to take up the cause.  “We’re not interested in marijuana as a 
gateway drug or any of that reefer madness.  We want to talk about dollars and cents,” says Allen 
St. Pierre, executive director of NORML (the National Organization for the Reform of Marijuana 
Laws). “If the idea here is saving money, then there’s no question that medical marijuana should 
be a part of the gambit of choices that doctors, patients and employers can have (Marijuana 
Reimbursement Claims Highlight How Pot Could be Gold for Employers, 2010).”  Though it 
seems logical that using medical marijuana would save us money on health care, this theory has 
really not been tested.  “No formal, peer-reviewed study of the cost-effectiveness of medical 
marijuana has been conducted,” says Jeffery Miron, an economist at Harvard University who has 
written about the cost of the federal prohibition against marijuana.  And while $1.1 billion has 
been budgeted to compare the effectiveness of different treatments for the same condition, there 
is no plan to research the effectiveness of medical marijuana, says a spokeswoman for the 
Agency for Healthcare Research and Quality (Marijuana Reimbursement Claims Highlight How 
Pot Could be Gold for Employers, 2010).” 
      With more and more states legalizing medical marijuana, one might wonder when this 
medication is prescribed if it is covered under any health insurance plans like other prescription 
drugs.  At this time, the answer is no.  Paying in cash is the common way to cover the costs of 
this treatment.  Most insurance agencies are in multiple states, making it difficult to standardize 
policy when medical marijuana is legal in one state and not in another.  Legalizing medical 
marijuana on a federal level would be the only way to eliminate this obstacle.  A larger issue is 
the fact that medical marijuana is not approved by the FDA.  “Lack of FDA approval means no 
coverage either by private insurers or through any public plan to be drafted by Congress (Walker, 
2009).”  Because marijuana is a plant it is very difficult to control its ingredients and insure that 
patients are getting a consistent product.  The FDA’s Karen Riley told Hotsheet that “the 
organization does not discuss whether specific drugs are being considered for approval.  But 
since marijuana lacks clear components or standardized doses – and since it is not even clear 
who might submit it for consideration – it seems extremely unlikely that medical marijuana is 
going through the process (Walker, 2009).”   
 
Court Cases 
 
     Arguably the case with the most media presence has been that of Joseph Casias of Battle 
Creek, Michigan.  Joseph has an inoperable brain tumor.  He received his medical marijuana card 
and was following the guidelines of the law.  In 2009, he was working at Walmart and had a 
workplace accident causing him to twist his knee.  Drug testing post-accident is common 
company policy.  Casias tested positive for marijuana and was subsequently fired.  He maintains 
that his oncologist had suggested trying marijuana and that he was not using it on the job.  On 
February 11, 2011, a federal judge ruled on the case.  “The fundamental problem with (Casias') 
case is that the (medical marijuana law) does not regulate private employment,” U.S. District 
Judge Robert Jonker wrote in a 20-page opinion.  The law protects the patient from prosecution, 
but does not require employers to accommodate the use of the drug (Judge Upholds Walmart’s 
Firing of Michigan Medical Marijuana User, 2011).”  Another issue is that Walmart is located in 
every state in the United States.  They are headquartered in Arkansas.  Medical marijuana is not 
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legal federally or in Arkansas.  Allowing use in states that have legalized medical marijuana 
would create issues with the consistency of the policies and procedures that employees of the 
company are expected to follow.   
     In another case, a patient who prefers to remain anonymous had her home raided and the 
small amount of marijuana that she had confiscated.  Her doctor had suggested marijuana to ease 
the pain of her fibromyalgia.  The raid happened in March of 2010 and the state did not begin to 
issue cards until April 2010.  Prior to this case, possession of a medical marijuana card was 
required.  “A gray area of the law, attorneys have said, is that while police may be unable to 
determine if a person without documentation is legally possessing marijuana, a so-called 
“affirmative defense” provision in the law broadens the definition of a patient to anyone who can 
document a covered medical condition or to whom a physician recommends it for treatment, 
regardless of whether they can produce state documentation (Killian, 2010).”  The misdemeanor 
marijuana charge was dropped against the woman.  James Nicholson, an Ottawa County man 
was arrested for possession of marijuana.  He had not received his card yet, but did have a copy 
of his application.  Two lower courts did not side with Nicholson, but in June 2012, the Court of 
Appeals ruled that “medical marijuana patients can be given immunity from prosecution if they 
show their registry card to the courts (Miller, 2012).”  Cases like this have helped out the 
movement to allow a doctor’s letter of approval or prescription to be used instead of requiring 
patients to register with the state.  Currently, qualifying patients must register with the Michigan 
Department of Licensing and Regulatory Affairs, Bureau of Health Care Services and possess a 
card.   
 The city of Wyoming, Michigan tried to ban the use of medical marijuana through a city 
ordinance.  Other cities within the state tried to do this as well.  John Ter Beek, a medical 
marijuana patient, sued the city.  In August 2012, the Court of Appeals ruled against the city.  
Their argument was that the state allows this, so cities within the state cannot ban it.  Patients 
should not have to fear prosecution (Smith, 2012). 
 
RECOMMENDATIONS 
 
     The federal government needs to remove marijuana as schedule 1 drug.  A major hurdle that 
medical marijuana faces is that, due to its schedule 1 status, human testing cannot be done to get 
genuine results on the effects.  Some studies talk about marijuana reversing low-level cancers.  
What if this is actually true and people could receive such a simple addition to their other 
treatments and potentially prolong their lives?  
     When the Michigan Supreme court rules in 2013, hopefully the result will be to allow for 
dispensaries to operate.  The Michigan Supreme Court does not typically hear appeal cases.  
Traditionally when they do hear cases that have been ruled upon by the Michigan Court of 
Appeals, they see some issue with the lower court’s interpretation of the law.  In this case, the 
law is silent and does not specifically allow for dispensaries, nor does it outlaw them.  Currently, 
Michigan does not have an effective way for many patients who are aided by medical marijuana 
to acquire it. “This summer, the Michigan Court of Appeals ruled that local governments 
couldn’t use ordinances to criminalize medical marijuana and that a man could not be prosecuted 
because he did not have his registration card at the time of his arrest. A four-bill package now in 
the Legislature would clarify some of the murkier aspects of the original legislation, including 
mandating that patients actually see the doctors who approve their cards, rather than consult via 
teleconference or other means (Deringer, 2012).”  All of this will help make interpretation of the 
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law easier for everyone involved.  Part of the package is to allow patients to have their 
prescription from the doctor as proof of eligibility.  Actually going to doctor will help weed out 
the individuals who are simply trying to use marijuana recreationally and are using the law to 
procure their marijuana.   
     The final recommendation would be for both sides to try to look at it from each other’s 
perspective.  Has Bill Schuette, Michigan Attorney General, spent any time interviewing 
legitimate patients that medical marijuana has helped?  Have dispensaries sat with legislatures as 
they try to untangle the Michigan Medical Marijuana Act?  Has the 30 year old man with the bad 
knee thought about how getting his card has impacted how those outside of the industry view the 
average card holder?  Perception can go a long way in bringing all sides together.    
 
CONCLUSION 
 
     Medical marijuana has growing support from citizens across the United States.  Michigan 
voters approved medical marijuana just over four years ago.  In this time, slow progress has been 
made in untangling the nuances of the law.  As more and more states legalize marijuana, 
Michigan will be looked at as an example for what should and should not be done.  This fall, 
Colorado and Washington took marijuana one step further, and legalized it for recreational use.  
Michigan and its citizens need to come to consensus so that patients and caregivers can function 
legally within the constraints of the law without fear of prosecution.   
 
REFERENCES 
 
      Department of Licensing and Regulatory Affairs. About the Medical Marihuana Program. 
Michigan Department of Community Health. Retrieved from 
http://www.michigan.gov/mdch/0,1607,7-132-27417_51869_52136---,00.html 
    Deringer, Nancy. September 18, 2012. Michigan marijuana industry ruled by confusion and 
anxiety. Grand Rapids Press/Mlive. Retrieved from  
http://www.mlive.com/health/index.ssf/2012/09/michigan_marijuana_industry_ru.html 
     Does smoking marijuana give you cancer? (2008). Retrieved from http://www.health-
insurance.org/marijuana-use-linked-to-cancer 
    Foreman, Judy. July 20, 2009. Medical marijuana science, through the smoke. LA Times.  
Retrieved from http://articles.latimes.com/2009/jul/20/health/he-marijuana20 
     Glaucoma and marijuana use. National eye institute. 2009.   
     Hall, J., Schiefelbein, J. (2011) The political economy of medical marijuana laws.  Atlantic 
Economic Journal, Vol. 39 Issue 2, p197-198. 
     Hoffmann, D., Weber, E., (2010) Medical Marijuana and the Law.  The New England Journal 
of Medicine, Vol. 362 Issue 16, p1453-1457 
     Jacobs, Terry. December 19, 2005. International Drug Scheduling; Convention on 
Psychotropic Substances; Single Convention on Narcotic Drugs; Butorphanol; Delta-9-
tetrahydrocannabinol (Dronabinol); Gamma-Hydroxybutyric Acid; Ketamine, Individual 
comment. Retrieved from: http://www.fda.gov/ohrms/dockets/dockets/05n0479/05N-0479-
EC2.htm  
     Johnson, Carrie. October 20, 2009.     U.S. eases stance on medical marijuana. Washington 
Post. Retrieved from  
 http://www.washingtonpost.com/wp-dyn/content/article/2009/10/19/AR2009101903638.html 
  Jackson/Medical Marijuana Act 
12 
 
     Judge upholds Walmart's firing of Michigan medical marijuana user. (2011). Grand Rapids 
Press/Mlive Retrieved from: 
http://www.mlive.com/news/grandrapids/index.ssf/2011/02/judge_upholds_walmarts_firing.html 
     Killian, Chris. February 27, 2010. Charge dismissed in medical marijuana case in Kalamazoo; 
ruling gets into gray area of state law. Kalamazoo Gazette/Mlive.  Retrieved from  
http://www.mlive.com/news/kalamazoo/index.ssf/2010/02/charged_dismissed_in_medical_m.ht
ml 
Klijn, E., Trust in Governance Networks:  Looking for Conditions for Innovative Solutions and 
Outcomes.  The New Public Governance.  Chapter 17 p303-318. 
     Knoll, Corina. February 4, 2009. Debate rages over DEA raid of westside medical marijuana 
dispensaries. Retrieved from: http://latimesblogs.latimes.com/lanow/2009/02/a-rally-is-plan.html 
     Kullgren, Ian. August 27, 2011. Michigan court of appeals rules commercial marijuana sales 
illegal. The State News. Retrieved from  
http://statenews.com/index.php/article/2011/08/michigan_court_of_appeals_rules_commercial_
marijuana_sales_illegal 
    Marijuana and medicine – assessing the science base. (1999). Institute of Medicine.  National 
Academy Press:  Washington D.C.  
     Marijuana reimbursement claims highlight how pot could be gold for employers. (2010). 
Retrieved from Workforce.com  http://www.workforce.com/section/02/feature/26/54/51/ 
     Medical Marijuana Producers See Bright Future For Entrepreneurs. (2010). Retrieved from 
Current.com. http://current.com/news/90642840_medical-marijuana-producers-see-bright-future-
for-entrepreneurs.htm 
     Medical Marijuana Soon Legal in Michigan. (2009). Chicago Tribune.  Retrieved from: 
http://www.chicagobreakingnews.com/2009/03/medical-marijuana-midwest-michigan.html 
     Medicinal Benefits of Marijuana.  (2003). Retrieved from 
https://www.wamm.org/old/medicinalbenefits.htm 
    Miller, Rina. June 28, 2012. Medical marijuana patient wins round in Michigan Court of 
Appeals. Michigan Radio. Retrieved from http://www.michiganradio.org/post/medical-
marijuana-patient-wins-round-michigan-court-appeals 
     Montoli, Brian. November 9, 2009. Does the pot pill work?” CBS News. Retrieved from 
 http://www.cbsnews.com/stories/2009/08/03/health/main5209380.shtml?tag=mncol;lst;1 
     Reinarman, C., Nunberg, H., Lanthier, Fran., Heddleston, T., (2011) Who are medical 
marijuana patients?  Population characteristics from nine California assessment clinics. Journal 
of Psychoactive Drugs, 43(2), p128-135. 
  Smith, Lindsey. August 1, 2012. City of Wyoming's medical marijuana ban goes up in smoke. 
Michigan Radio.  Retrieved from http://www.michiganradio.org/post/city-wyomings-medical-
marijuana-ban-goes-smoke 
     Smoking gun:  the impact of cannabis smoking on respiratory health. (2002). British Lung 
Foundation.    
     Walker, Chris. October 28, 2009. Will health coverage pay for medical marijuana? Retrieved 
from  
http://www.articlesbase.com/insurance-articles/will-health-coverage-pay-for-medical-marijuana-
1389100.html#axzz0m90ALp6t 
 
 
 
Jackson/Michigan Medical Marijuana Act 
 
13 
 
  
 
Amy Van Prooyen is a Senior Benefits Specialist for Spectrum 
Health Systems and currently resides in Grand Rapids, 
Michigan.  She recieved her Masters in Health Administration 
from Grand Valley State University in December of 2012 and was 
awarded the Dean's Citation of Academic Excellence.  She is 
excited about opportunities this degree will open up within 
Spectrum.  Amy earned her Bachelor of Arts in Communications 
from Michigan State University.   
 
